Aprea Therapeutics
APRE
Aprea Therapeutics (APRE) news
Recent news
Aprea Therapeutics Q2 EPS USD -0.07
AInvest Wire · Aug 12, 2026Aprea Therapeutics announces second quarter 2026 financial results
AInvest Wire · Aug 12, 2026Aprea Therapeutics announces FDA clearance of IND for Apr-1051, its next generation Wee1 kinase inhibitor for cyclin E overexpressing cancers
Aprea Therapeutics announces FDA clearance of IND for Apr-1051, its next generation Wee1 kinase inhibitor for cyclin E overexpressing cancers Aprea Therapeutics, a clinical-stage biopharmaceutical company, has announced that the US Food and Drug Administration (FDA) has cleared the Investigational…
AInvest Wire · Mar 11, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.